Biocryst Pharmaceuticals Ratios (2010-2015) | BCRX

Ratios Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015
Profitability
Gross Margin 100.00%100.00%99.51%100.00%99.84%97.89%99.66%100.00%99.21%99.12%97.97%87.75%
EBT Margin -90.53%-61.11%-408.92%-264.30%-231.97%525.00%972.33%-181.85%-1,618.27%-338.97%-71.50%-249.02%-874.83%-395.71%-301.63%-228.95%19.07%-129.87%
EBIT Margin -91.58%-61.75%-381.34%-243.95%-211.37%431.12%877.24%-149.58%-1,478.93%-289.87%-59.94%-213.59%-792.56%-358.55%-278.30%-211.40%24.53%-119.80%
EBITDA Margin -91.58%-61.75%-435.39%-243.95%-211.37%520.95%1,059.05%-127.12%-1,483.68%-335.08%-51.36%-293.20%-999.18%-269.67%-216.75%-220.10%22.04%-132.25%
Operating Margin -91.58%-61.75%-381.34%-243.95%-211.37%431.12%877.24%-149.58%-1,478.93%-289.87%-59.94%-213.59%-792.56%-358.55%-278.30%-211.40%24.53%-119.80%
Net Margin -90.53%-61.11%-408.92%-264.30%-231.97%525.00%972.33%-181.85%-1,618.27%-338.97%-71.50%-249.02%-874.83%-395.71%-301.63%-228.95%19.07%-129.87%
FCF Margin -77.44%-34.94%-93.55%-199.47%-76.28%1,061.81%550.17%-315.08%-352.62%-331.60%-42.77%-259.28%-484.45%-266.65%-256.24%-62.86%81.41%-116.52%
Efficiency
Inventory Average 0.90M0.58M0.26M
Assets Average 100.46M87.36M81.15M78.16M70.17M60.77M52.17M43.41M46.56M51.04M46.13M92.68M139.55M137.00M133.37M140.02M144.57M
Equity Average 32.65M20.42M18.98M19.40M12.72M4.67M-1.65M-5.94M-2.82M1.14M-3.42M42.18M86.77M79.54M70.00M70.23M70.07M
Invested Capital 65.50M39.27M26.04M14.81M23.15M15.66M9.78M-0.45M-2.84M-9.05M3.41M-1.13M-5.72M90.09M83.45M75.64M64.37M76.09M64.05M
Asset Utilization Ratio 0.260.160.160.100.04-0.040.050.100.150.340.370.190.130.100.130.270.31
Leverage & Solvency
Interest Coverage Ratio -12.22-11.04-9.52-4.31-8.77-4.51-10.42-5.81-5.10-5.95-9.48-9.54-11.53-10.974.09-10.61
Debt to Equity 0.761.152.031.301.923.07-66.08-10.56-3.328.80-26.64-5.240.400.470.390.47
Debt Ratio 0.280.320.360.370.390.470.520.640.750.560.610.690.220.230.200.22
Equity Ratio 0.600.360.280.180.290.210.15-0.01-0.06-0.230.06-0.02-0.130.630.610.550.500.510.46
Times Interest Earned -12.22-11.04-9.52-4.31-8.77-4.51-10.42-5.81-5.10-5.95-9.48-9.54-11.53-10.974.09-10.61
Valuation
Enterprise Value -11.17M-53.95M-31.34M-57.59M-44.00M-41.72M-43.28M-23.96M-35.60M-14.80M-19.77M-42.59M-38.05M-31.39M-132.11M-127.13M-72.77M-67.53M-94.36M-70.33M
Return Ratios
Return on Sales -0.91%-0.61%-4.09%-2.64%-2.32%5.25%9.72%-10.15%7.49%-1.82%-16.18%-3.39%-0.71%-2.49%-8.75%-3.96%-3.02%-2.29%0.19%-1.30%-0.65%
Return on Capital Employed -0.60%-0.79%-0.66%-0.66%-0.77%-1.04%-1.04%-0.86%-1.01%-0.68%-0.41%-0.57%-0.74%-0.47%-0.47%
Return on Assets -0.39%-0.47%-0.58%-0.55%-0.42%-0.29%-0.34%-0.45%-0.60%-0.69%-0.81%-0.40%-0.30%-0.37%-0.43%-0.29%-0.29%
Return on Equity -1.20%-2.02%-2.50%-2.23%-2.32%-3.72%10.77%3.32%9.88%-31.00%10.97%-0.88%-0.48%-0.64%-0.82%-0.58%-0.60%